(IBC3) iShares Core MSCI EM IMI - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BD45KH83 • Global Emerging Markets Equity
IBC3: Stocks, Bonds, Emerging Markets
The iShares Core MSCI EM IMI UCITS ETF (XETRA: IBC3) is a low-cost, broadly diversified exchange-traded fund designed to provide exposure to emerging markets equities. It tracks the Morningstar Emerging Markets Total Return Net Index, which includes large-, mid-, and small-cap stocks across 27 emerging market countries. This fund is domiciled in Ireland and structured as a UCITS-compliant ETF, making it accessible to European investors while adhering to strict regulatory standards.
With a market capitalization of 19.95 billion EUR, this ETF is one of the larger funds in its category, offering liquidity and scale. It provides a cost-effective way to gain exposure to a wide range of emerging markets, from BRICS nations to smaller, fast-growing economies. The fund’s expense ratio is competitive, typically lower than many actively managed emerging market strategies, making it a popular choice for long-term investors seeking efficient market exposure.
Investors should note that this ETF is designed for those who want broad diversification across emerging markets without the need to select individual stocks or time the market. It is structured to replicate the performance of its underlying index, net of fees and expenses. While emerging markets can be volatile, this fund offers a way to participate in the long-term growth potential of these economies while managing risk through diversification.
For fund managers and institutional investors, this ETF can serve as a core holding or a tactical allocation within a broader portfolio. Its UCITS structure ensures transparency, regulatory compliance, and ease of trading on the XETRA exchange. Additionally, the fund’s large size and liquidity make it suitable for both retail and institutional investors looking to gain efficient exposure to emerging markets.
Additional Sources for IBC3 ETF
IBC3 ETF Overview
Market Cap in USD | 21,633m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2018-03-05 |
IBC3 ETF Ratings
Growth 5y | 53.4% |
Fundamental | - |
Dividend | 47.3% |
Rel. Strength Industry | -13.3 |
Analysts | - |
Fair Price Momentum | 4.31 EUR |
Fair Price DCF | - |
IBC3 Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 4.21% |
Annual Growth 5y | 3.41% |
Payout Consistency | 95.1% |
IBC3 Growth Ratios
Growth Correlation 3m | 1.3% |
Growth Correlation 12m | 79.5% |
Growth Correlation 5y | 41.6% |
CAGR 5y | 10.30% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | 1.17 |
Alpha | 1.54 |
Beta | 0.64 |
Volatility | 17.05% |
Current Volume | 178.1k |
Average Volume 20d | 123.2k |
As of March 14, 2025, the stock is trading at EUR 4.42 with a total of 178,100 shares traded.
Over the past week, the price has changed by -1.83%, over one month by -4.73%, over three months by -3.80% and over the past year by +8.29%.
Partly, yes. Based on ValueRay Analyses, iShares Core MSCI EM IMI (XETRA:IBC3) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.42 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBC3 as of March 2025 is 4.31. This means that IBC3 is currently overvalued and has a potential downside of -2.49%.
iShares Core MSCI EM IMI has no consensus analysts rating.
According to ValueRays Forecast Model, IBC3 iShares Core MSCI EM IMI will be worth about 4.8 in March 2026. The stock is currently trading at 4.42. This means that the stock has a potential upside of +7.92%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 4.8 | 7.9% |